Impact of screening on prostate cancer rates and trends

Microscopy Research and Technique

Volumn 51, Issue 5, 2000, Pages 415-418

  Mettlin, Curtis ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Epidemiology; Incidence; Mortality; Patterns of care; Prostate specific antigen

Indexed keywords

ANTIGENS; DIAGNOSIS; DISEASES; POPULATION STATISTICS; UROLOGY;

CANCER CONTROL; CANCER SCREENING; CONTROL STRATEGIES; INCIDENCE; MORTALITY; MULTIPLE SOURCE; PATTERNS OF CARE; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; REGIONAL RESOURCES;

TUMORS;

PROSTATE SPECIFIC ANTIGEN;

CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; UNITED STATES;

EID: 0034565120     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20001201)51:5<415::AID-JEMT2>3.0.CO;2-B     Document Type: Review

References (18)

1. Barchielli A, Crocetti E, Zappa M. 2000. Has the PSA wave already crashed upon us? Changes in the epidemiology of prostate cancer from 1985 to 1994 in central Italy. Ann Oncol 10:361-362.
2. Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. 1999. Cancer Surveillance Series: interpreting trends in prostate cancer, Part III. Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 91:1033-1039.
3. Feuer E, Merrill RM, Hankey BF. 1999. Cancer Surveillance Series: interpreting trends in prostate cancer, Part II. Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 91:1025-1032.
4. Friedman GD, Hiatt RA, Quesenberry CP, Selby JV. 1991. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 337:1526-1529.
5. Gohagan J, Prorok P, Kramer B. 1995. The prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. Cancer 75:1869-1873.
6. Jacobsen SJ, Bergstralh EJ, Katusic SK, Guess HA, Darby CH, Silverstein MD, Oesterling JE, Lieber MM. 1998. Screening digital rectal examination and prostate cancer mortality: a population-based case control study. Urology 52:173-179.
7. Mettlin CJ, Murphy GP, Ho R, Menck HR. 1996. The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer 77:2162-2166.
8. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. 1998. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. Cancer 83:1679-1684.
9. Mettlin CJ, Murphy GP, McDonald CJ, Menck HR. 1999. The National Cancer Data Base report on increased use of brachytherapy for treatment of prostate carcinoma in the U. S. Cancer 86:1632-1634.
10. Meyer F, Moore L, Bairati I, Fradet Y. 1998. Downward trend in prostate cancer mortality in Quebec and Canada. J Urol 161:1189-1191.
11. Post PN, Kil PJM, Crommelin MA, Schapers RFM, Coebergh J-WW. 1998. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction, a registry-based study in southeastern Netherlands, 1971-1995. Eur J Cancer 34:705-709.
12. Richert-Boe KE, Humphrey LL, Glass AG, Weiss NS. 1998. Screening digital rectal examination and prostate cancer mortality: a case-control study. J Med Screen 5:99-103.
13. Rietbergen JBW, Hoedemaeker RH, Kruger AEB, Kirkels WJ, Schroeder FH. 1999. The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. J Urol 161:1192-1198.
14. Roberts RO, Bergstralh EJ, Katusic SK, Lieber MM, Jacobsen SJ. 1999. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol 161:529-533.
15. Standaert B, Denis L. 1997. The European randomized study of screening for prostate cancer: an update. Cancer 80:1830-1834.
16. Stephenson RA. 1998. Population-based prostate cancer trends in the PSA era: data from the Surveillance, Epidemiology, and End Results (SEER) program. Monogr Urol 19:3-19.
17. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, Edwards BK. 1999. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91:675-690.
18. Wingo PA, Ries LAG, Rosenberg HM, Miller DS, Edwards BK. 1998. Cancer incidence and mortality, 1973-1995. A report card for the U.S. Cancer 82:1197-1207.